Analytical Data
-
Gene name
BAG-2
- Application
-
Alternative Names
Bcl-2-associated athanogene 2
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95816
-
Expression Region
1-211aa
-
Molecular Weight
50.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRP-10, also known as Low-Density Lipoprotein Receptor-Related Protein 10, is a member of the LDL receptor family that has garnered attention in recent years due to its potential roles in various physiological and pathological processes. This protein is thought to be involved in endocytic pathways and intracellular signaling, impacting cellular functions such as migration, proliferation, and survival. Research has shown that LRP-10 may play a critical role in the immune response, particularly in the regulation of cytokine production and T cell activation. Additionally, there is emerging evidence linking LRP-10 to neurodegenerative diseases, suggesting that it may influence neuronal health and synaptic function. The recombinant expression of LRP-10 offers a valuable tool for investigating its structure and function, facilitating the exploration of its interactions with other molecular partners. By producing the LRP-10 protein in a controlled laboratory setting, researchers aim to elucidate its biological significance, analyze its mechanisms of action, and assess its potential as a therapeutic target. This recombinant protein research represents a promising frontier in understanding not only LRP-10’s role in basic cellular processes but also its implications in disease, thereby opening avenues for new treatment strategies. The continued study of LRP-10 is crucial for advancing our knowledge of lipid metabolism, immune regulation, and neurobiology, making it a subject of great interest in molecular biology and biomedical research.
